Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomotaka Mabuchi

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
The Journal of Dermatology|December 30, 2022
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version)Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, et al.
The Journal of Dermatology|May 3, 2023
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasisHidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, et al.
The Tokai Journal of Experimental and Clinical Medicine|July 1, 2020
Cutaneous Metastases from Testicular Diffuse Large B-cell Malignant Lymphoma and Bowen Disease: 18F-FDG PET-CT FindingsTatsuya Mikami, Tamaki Ichikawa, Toshiki Kazama, et al.
The Journal of Dermatology|November 20, 2016
Pediatric case of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma forming a solitary skin tumor on the forearmMichio Tokuyama, Yuta Kurashige, Tami Ota, et al.
The Tokai Journal of Experimental and Clinical Medicine|February 15, 2011
The incidence of internal malignancies in autoimmune bullous diseasesKenichi Iwashita, Takashi Matsuyama, Emiko Akasaka, et al.
Journal of Drugs in Dermatology : JDD|August 2, 2024
Benefits Over Five Years of Ixekizumab Treatment in Patients With Psoriasis Involving Challenging Body AreasAlice B Gottlieb, April Armstrong, Andrew Blauvelt, et al.
The Journal of Dermatology|August 4, 2017
Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologicsTakuro Kanekura, Mariko Seishima, Masaru Honma, et al.
The Tokai Journal of Experimental and Clinical Medicine|February 15, 2011
Fine mapping of a psoriasis-susceptibility locus within the HLA class II region by using microsatellite markers in an association study of Japanese cases and controlsTomotaka Mabuchi, Akira Oka, Mariko Iizuka, et al.
The Journal of Dermatology|September 20, 2018
Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPPHideki Fujita, Tadashi Terui, Koremasa Hayama, et al.
Journal of Dermatological Science|January 26, 2021
Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE studyShinichi Imafuku, Yasumasa Kanai, Kenta Murotani, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Dermatology|December 30, 2022
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version)Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, et al.
The Journal of Dermatology|May 3, 2023
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasisHidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, et al.
The Tokai Journal of Experimental and Clinical Medicine|July 1, 2020
Cutaneous Metastases from Testicular Diffuse Large B-cell Malignant Lymphoma and Bowen Disease: 18F-FDG PET-CT FindingsTatsuya Mikami, Tamaki Ichikawa, Toshiki Kazama, et al.
The Journal of Dermatology|November 20, 2016
Pediatric case of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma forming a solitary skin tumor on the forearmMichio Tokuyama, Yuta Kurashige, Tami Ota, et al.
The Tokai Journal of Experimental and Clinical Medicine|February 15, 2011
The incidence of internal malignancies in autoimmune bullous diseasesKenichi Iwashita, Takashi Matsuyama, Emiko Akasaka, et al.
Journal of Drugs in Dermatology : JDD|August 2, 2024
Benefits Over Five Years of Ixekizumab Treatment in Patients With Psoriasis Involving Challenging Body AreasAlice B Gottlieb, April Armstrong, Andrew Blauvelt, et al.
The Journal of Dermatology|August 4, 2017
Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologicsTakuro Kanekura, Mariko Seishima, Masaru Honma, et al.
The Tokai Journal of Experimental and Clinical Medicine|February 15, 2011
Fine mapping of a psoriasis-susceptibility locus within the HLA class II region by using microsatellite markers in an association study of Japanese cases and controlsTomotaka Mabuchi, Akira Oka, Mariko Iizuka, et al.
The Journal of Dermatology|September 20, 2018
Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPPHideki Fujita, Tadashi Terui, Koremasa Hayama, et al.
Journal of Dermatological Science|January 26, 2021
Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE studyShinichi Imafuku, Yasumasa Kanai, Kenta Murotani, et al.
Pageof 8